Severity of Death when taking Tysabri ** :
How people recovered from Death ** :
Robnl wrote:How can it be that this is still prescribed???
Ahh, 30000$ per year per patient.....logical
Dr. Steinman said he had expressed his apprehensions about the drug in speeches and in an article in the journal Science in July and had been asked by Biogen executives to tone down criticism of the drug.
Did you mention in the past that the number of lesions is not indicative of disease progression, disability progression?
Is Tysabri supposed to slow disease progression, lesion formation, or disability progression?
A prospective, observational, single-blinded, longitudinal study of natalizumab effect on brain atrophy and disability in multiple sclerosis patients over 5 years.
Role: R. Zivadinov, PI
Agency: Biogen Idec, Inc.
Aim: To define the effect of the number of natalizumab cycles on development of brain atrophy and progression of disability in originally treated patients with natalizumab in relapsing multiple sclerosis.
Period: May 2012 –December 2013
erinc14 wrote:how come the media never talks about drug deaths but they always report any negative news regarding ccsvi.
marcstck wrote:I'm no fan of big Pharma, but the fact is that Tysabri has dramatically increased the quality of life for a majority of patients taking it. Not that the drug is without its problems, as the PML threat is quite troubling. But careful patient monitoring for JC virus status seems to be helping the situation, and the most recent studies do seem to indicate that the drug may even limit disease progression.
Users browsing this forum: No registered users